$175K in pilot grants awarded to UC cancer researchers
Pilot grants totaling $175,000 were recently awarded to University of Cincinnati (UC) researchers to fund projects dedicated to advancing science and finding new therapies for pancreatic and head and neck cancers.
Xiaoyang Qi, PhD, and Fukun Guo, PhD
GIVEHOPE Pancreatic Cancer Research and Awareness Fund:
$47,500 to Xiaoyang Qi, PhD, professor in the Division of Hematology Oncology, member of the Cincinnati Cancer Center and UC Cancer Institute. Qi and his team will study a cellular structure and function in metastatic pancreatic cancer cells and determine the therapeutic efficacy of nanovesicles by blocking certain cancer-causing pathways in cancer development and spread.
$47,500 to Fukun Guo, PhD, associate professor in the Department of Pediatrics and a researcher at Cincinnati Children’s. Guo and his team will determine the efficacy of chemical targeting of animal and human regulatory T cells (a type of white blood cells) as a way to trigger immunity against pancreatic tumor formation.
Yana Zavros, PhD
Steven Goldman Memorial Pancreatic Cancer Research Grant:
$55,000 to Yana Zavros, PhD, professor in the Department of Pharmacology and Systems Physiology, and her team. As Zavros received funds from the Goldman grant last year, her continuing project will focus on putting individual pancreatic cancer patient immune cells into an organoid culture to predict the best treatment for that person. An organoid is a three-dimensional, multicellular miniaturized version of the tissue or organ from which it was derived. The hope is that this personalized assessment will improve outcomes for patients.
Vinita Takiar, MD, PhD
Brandon C. Gromada Head and Neck Cancer Foundation Research Fund:
$25,000 to Vinita Takiar, MD, PhD, assistant professor in the Department of Radiation Oncology and member of the UC Cancer Institute, and her multidisciplinary team including medical oncologist Trisha Wise-Draper, MD, surgeon Alice Tang, MD, and post-doctoral fellow Christina Wicker, PhD. Their project will collect pilot data for a new approach to treatment of head and neck cancers by looking first at patient-derived organoids. Growing tumors in the lab directly from patients will provide the researchers with a new way to study head and neck cancers and test treatment options.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.